These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 17227229)

  • 1. NF-kappa B as a therapeutic target in neurodegenerative diseases.
    Camandola S; Mattson MP
    Expert Opin Ther Targets; 2007 Feb; 11(2):123-32. PubMed ID: 17227229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct roles of diverse nuclear factor-kappaB complexes in neuropathological mechanisms.
    Pizzi M; Spano P
    Eur J Pharmacol; 2006 Sep; 545(1):22-8. PubMed ID: 16854410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NF-kappaB in the survival and plasticity of neurons.
    Mattson MP
    Neurochem Res; 2005; 30(6-7):883-93. PubMed ID: 16187223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual roles of NF-kappaB in cell survival and implications of NF-kappaB inhibitors in neuroprotective therapy.
    Qin ZH; Tao LY; Chen X
    Acta Pharmacol Sin; 2007 Dec; 28(12):1859-72. PubMed ID: 18031598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signaling via NF-kappaB in the nervous system.
    Kaltschmidt B; Widera D; Kaltschmidt C
    Biochim Biophys Acta; 2005 Sep; 1745(3):287-99. PubMed ID: 15993497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles for NF-kappaB in nerve cell survival, plasticity, and disease.
    Mattson MP; Meffert MK
    Cell Death Differ; 2006 May; 13(5):852-60. PubMed ID: 16397579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Nuclear Factor Kappa B (NF-κB) Signalling in Neurodegenerative Diseases: An Mechanistic Approach.
    Singh S; Singh TG
    Curr Neuropharmacol; 2020; 18(10):918-935. PubMed ID: 32031074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(ADP-ribose) polymerase-1 activity promotes NF-kappaB-driven transcription and microglial activation: implication for neurodegenerative disorders.
    Chiarugi A; Moskowitz MA
    J Neurochem; 2003 Apr; 85(2):306-17. PubMed ID: 12675907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pro-apoptotic effects of lipid oxidation products: HNE at the crossroads of NF-κB pathway and anti-apoptotic Bcl-2.
    Timucin AC; Basaga H
    Free Radic Biol Med; 2017 Oct; 111():209-218. PubMed ID: 27840321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear factor-kappa B: a transcription factor for all seasons.
    Aggarwal BB
    Expert Opin Ther Targets; 2007 Feb; 11(2):109-10. PubMed ID: 17227227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF-kappa B as a therapeutic target in autoimmune disease.
    O'Sullivan B; Thompson A; Thomas R
    Expert Opin Ther Targets; 2007 Feb; 11(2):111-22. PubMed ID: 17227228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nuclear factor-kappaB (NF-kappaB): from a versatile transcription factor to a ubiquitous therapeutic target.
    Yates LL; Górecki DC
    Acta Biochim Pol; 2006; 53(4):651-62. PubMed ID: 17068636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NF-κB signaling pathways: role in nervous system physiology and pathology.
    Mincheva-Tasheva S; Soler RM
    Neuroscientist; 2013 Apr; 19(2):175-94. PubMed ID: 22785105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of NF-κB in astrocytes is sufficient to delay neurodegeneration induced by proteotoxicity in neurons.
    Li YX; Sibon OCM; Dijkers PF
    J Neuroinflammation; 2018 Sep; 15(1):261. PubMed ID: 30205834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential therapeutic targets in the NF-kappaB pathway for Alzheimer's disease.
    Collister KA; Albensi BC
    Drug News Perspect; 2005 Dec; 18(10):623-9. PubMed ID: 16491164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NF-kappaB functions in the nervous system: from development to disease.
    Mémet S
    Biochem Pharmacol; 2006 Oct; 72(9):1180-95. PubMed ID: 16997282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear factor-kappa B: from clone to clinic.
    Ahn KS; Sethi G; Aggarwal BB
    Curr Mol Med; 2007 Nov; 7(7):619-37. PubMed ID: 18045141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NF-kappa B1 p50 is required for BLyS attenuation of apoptosis but dispensable for processing of NF-kappa B2 p100 to p52 in quiescent mature B cells.
    Hatada EN; Do RK; Orlofsky A; Liou HC; Prystowsky M; MacLennan IC; Caamano J; Chen-Kiang S
    J Immunol; 2003 Jul; 171(2):761-8. PubMed ID: 12847243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Injury-induced NF-kappaB activation in the hippocampus: implications for neuronal survival.
    Kassed CA; Butler TL; Patton GW; Demesquita DD; Navidomskis MT; Mémet S; Israël A; Pennypacker KR
    FASEB J; 2004 Apr; 18(6):723-4. PubMed ID: 14766792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [NF-kappaB as a therapeutic target of rheumatoid arthritis].
    Okamoto T; Tsuchiya A
    Nihon Rinsho Meneki Gakkai Kaishi; 2007 Oct; 30(5):383-9. PubMed ID: 17984578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.